Trial Details

Recruiting
Basic Information
Clinical ID c5234
Identifier ChiCTR2400089738
Trial Title Evaluation of the safety, tolerability, pharmacokinetic profile and food effects of AC-101 tablets in healthy subjects: a single-center, randomized, double-blind, placebo-controlled, multiple-dose phase I clinical study
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Inflammatory Bowel Disease,IBD
Interventions 300 mg:300 mg/cycle;100 mg(BID):AC-101 tablets: 100 mg times/day, Placebo:1 tablet times/day;200 mg(QD):AC-101 tablets: 200 mg time/day; Placebo: 2 tablets x 1 time/day;
Participant Information
Sponsor The Second Affiliated Hospital of Anhui Medical University
City NULL
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type Interventional study
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL